Data presented at the EuroPCR 2012 congress this week demonstrated that in more than 10, 000 real-world patients treated with XIENCE PRIME and XIENCE V, no cases of stent thrombosis were reported in patients who discontinued DAPT after three months post-stent implantation.
FORBES: Xience Stents Gain European Nod For Three-Month Dual Antiplatelet Therapy